Stock That Is Worth Exploring Now: Strategy (NASDAQ: MSTR)

Strategy (NASDAQ:MSTR) does about 15.51M shares in volume on a normal day but saw 8011050 shares change hands in the recent trading day. The company now has a market cap of 104.51B USD. Its current market price is $382.25, marking a decrease of -0.16% compared to the previous close of $382.87. The 52 week high reached by this stock is $543.00 whilst the lowest price level in 52 weeks is $102.40. The script in recent trading has seen the stock touch a high of $220 and a low of $220.

6 analysts observing the Strategy (MSTR) stock have set the 12-month price targets for the company’s shares at between $220 and $220. The consensus objective for the share price is $527.20, suggesting that the stock has a potential upside of 27.49% over the period. The median price target is -73.75% away from the current levels at $220.

FactSet Research has provided data showing that 6 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 5 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on April 29, 2025 when H.C. Wainwright initiated the stock to “Buy” and issued a price target of $480. Monness Crespi & Hardt downgraded the stock to “Sell” from Neutral on April 01, 2025 at a price target of $220.

The current price level is -0.38%, 4.66%, and 26.03% away from its SMA20, SMA50, and SMA200 respectively, with the MSTR price moving above the 50-day SMA on current market day. Strategy (MSTR) stock is down -2.52% over the week and -3.72% over the past month. Its price is 31.98% year-to-date and 138.36% over the past year.

Its 12-month price target is $220. To reach the target analysts have set, the stock logically needs to grow 27.49 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $220, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $220.

The company has a return on investment of -12.80% and return on equity of -29.68%. The beta has a value of 3.76. Price to book ratio is 3.16 and price to sales ratio is 227.55.

Comet Reports
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.